期刊文献+

ABCB1基因多态性对乳腺癌化疗所致血液学毒性的影响观察 被引量:1

Effect of ABCB1 gene polymorphism on hematological toxicity in breast cancer patients receiving paclitaxel chemotherapy
下载PDF
导出
摘要 目的:探讨ABCB1基因多态性对乳腺癌化疗所致血液学毒性的影响观察。方法:选择92例乳腺癌患者作为研究对象并检测ABCB1基因分型,分析不同基因多态性患者的血液学毒性结果。结果:92例乳腺癌患者中,G2677T/A点位GG占15.22%、GT/A占57.60%、TT/AA/AT占27.18%;C3435T点位CC占23.91%、CT占54.35%、TT占21.74%;G2677T/A、C3435T基因型分布符合遗传平衡定律(P>0.05)。G2677T/A各基因型血液学毒性发生情况无差异(P>0.05);C3435T各基因型血液学毒性发生情况比较有差异(P<0.05)。G2677T/A各基因型和C3435T各基因型近期疗效比较无差异(P>0.05)。结论:检测ABCB1基因C3435T点位基因多态性对乳腺癌患者化疗具有重要的参考价值。 Objective:To investigate the effect of ABCB1 gene polymorphism on hematological toxicity caused by chemotherapy in breast cancer.Methods:Ninety-two breast cancer patients were selected as the research subjects and ABCB1 genotype was detected,and the hematological toxicity results of patients with different gene polymorphisms were analyzed.Results:Among the 92 breast cancer patients,GG accounted for 15.22%,GT/A accounted for 57.60%,TT/AA/AT accounted for 27.18%in G2677T/A site;CC accounted for 23.91%,CT accounted for 54.35%,and TT accounted for 21.74%in G3435T site;G2677T/A,C3435T genotype distribution conformed to the law of genetic equilibrium(P>0.05).There was no difference in the occurrence of hematological toxicity among G2677T/A genotypes(P>0.05).There were differences in the occurrence of hematological toxicity among C3435T genotypes(P>0.05).There was no difference in the short-term curative effect between the G2677T/A genotypes and the C3435T genotypes(P>0.05).Conclusion:Detection of ABCB1 gene C3435T locus polymorphism has important reference value for chemotherapy in breast cancer patients.
作者 李倩 王西勇 Li Qian;Wang Xiyong(Suzhou Hospital Affiliated to Anhui Medical University,Suzhou Anhui 234000)
出处 《现代科学仪器》 2022年第2期134-138,共5页 Modern Scientific Instruments
基金 安徽省高等学校自然科学研究项目(编号:KJ2020A1145) 宿州市科技攻关计划项目(编号:202019)。
关键词 ABCB1 单核苷酸多态性 紫杉醇 化疗 血液学毒性 ABCB1 single nucleotide polymorphism paclitaxel chemotherapy hematological toxicity
  • 相关文献

参考文献14

二级参考文献103

  • 1马秉亮,吴玉林,刘国卿.P-gp及对抗P-gp介导多药耐药的研究现状[J].中国临床药理学与治疗学,2006,11(1):14-21. 被引量:15
  • 2Lenz G, Staudt LM. Aggressive lymphomas [ J ]. N Engl J Med ,2010,362 ( 15 ) : 1 417 - 1 429. 被引量:1
  • 3Hoffmeyer S, Burk O, yon Richter O, et al. Functional poly- morphisms of the human multidrug-resistance gene : multiple sequence variations and correlation of one allele with P-gly- coprotein expression and activity in vivo [ J ]. Proc Natl Acad Sci USA,2000,97(7) :3 473 -3 478. 被引量:1
  • 4Fung KL, Gottesman MM. A synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein func- tion [ J ]. Biochim Biophys Acta,2009,1794 (5) : 860 - 871. 被引量:1
  • 5A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non- Hodgkin's Lymphoma Classification Project [ J]. Blood, 1997,89(11) :3 909 -3 918. 被引量:1
  • 6Cheson BD, Pfistner B, Juweid ME, et al. Revised response criteria for malignant lymphoma [ J ]. Clin Oncol, 2007,25 (5) :579 -586. 被引量:1
  • 7Miller AB, Hoogstraten B, Staquet M, et al. Reporting results of cancer treatment[ J]. Cancer, 1981,47( 1 ) :207 -214. 被引量:1
  • 8Coiffier B, Lepage E, Briere J, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly pa- tients with diffuse large-B-cell lymphoma [ J ]. N Eng/ J Med ,2002 ,346 (4) :235 - 242. 被引量:1
  • 9Friedberg JW. New strategies in diffuse large B-cell lympho- ma:translating findings from gene expression analyses into clinical practiee[ J]. Clin Caneer Res, 2011, 17 ( 19 ) : 6 112-6 117. 被引量:1
  • 10Shankland KR, Armitage JO, Hancock BW. Non-Hodgkin lymphoma [ J ]. Lancet ,2012,380 ( 9 844 ) : 848 - 857. 被引量:1

共引文献49

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部